Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of etanercept

被引：0
作者：
Llinares-Tello, Francisca [1 ]
Rosas-Gomez de Salazar, Jose [2 ]
Miguel Senabre-Gallego, Jose [2 ]
Santos-Soler, Gregorio [2 ]
Santos-Ramirez, Carlos [4 ]
Salas-Heredia, Esteban [2 ]
Molina-Garcia, Juan [3 ]
机构：
[1] Marina Baixa Hosp, Dept Lab, Alicante 03570, Spain
[2] Marina Baixa Hosp, Dept Rheumatol, Alicante, Spain
[3] Marina Baixa Hosp, Dept Lab, Alicante, Spain
[4] Marina Salud Hosp, Dept Rheumatol, Alicante, Spain
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2015年 / 53卷 / 10期
关键词：
ELISA; etanercept; therapeutic drug monitoring; COMMERCIALLY AVAILABLE METHODS; RHEUMATOID-ARTHRITIS; ADALIMUMAB; INFLIXIMAB;
D O I：
10.1515/cclm-2014-0898
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：E279 / E282
页数：4
相关论文
共 50 条
  • [31] Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts
    den Broeder, Alfons A.
    van Herwaarden, Noortje
    van den Bemt, Bart J. F.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (03) : 266 - 275
  • [32] Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?
    Emilio Perucca
    Clinical Pharmacokinetics, 2000, 38 : 191 - 204
  • [33] Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation
    Kim, Eun Sil
    Chon, Hyangah
    Kwon, Yiyoung
    Lee, Misook
    Kim, Mi Jin
    Choe, Yon Ho
    THERAPEUTIC DRUG MONITORING, 2024, 46 (04) : 460 - 467
  • [34] Development and evaluation of an immunoassay for the monitoring of the anti-HIV drug amprenavir
    Bastiani, Erica
    Benedetti, Fabio
    Berti, Federico
    Carnpaner, Pietro
    Donadel, Elena
    Montagna, Michela
    Regazzi, Mario
    Rinaldi, Serena
    Savoini, Adriano
    Venturini, Rornina
    JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 325 (1-2) : 35 - 41
  • [35] Clinical experience combined with therapeutic drug monitoring of lacosamide
    Svendsen, Torleiv
    Brodtkorb, Eylert
    Baftiu, Arton
    Lossius, Morten, I
    Nakken, Karl O.
    Johannessen, Svein, I
    Landmark, Cecilie Johannessen
    ACTA NEUROLOGICA SCANDINAVICA, 2020, 141 (04): : 279 - 286
  • [36] Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives
    Yew, WW
    CLINICA CHIMICA ACTA, 2001, 313 (1-2) : 31 - 36
  • [37] Clinical benefit of interventions driven by therapeutic drug monitoring
    Rendón, AL
    Núñez, M
    Jiménez-Nácher, I
    de Requena, DG
    González-Lahoz, J
    Soriano, V
    HIV MEDICINE, 2005, 6 (05) : 360 - 365
  • [38] Therapeutic drug monitoring of inununosuppressant drugs in clinical practice
    Kahan, BD
    Keown, P
    Levy, GA
    Johnston, A
    CLINICAL THERAPEUTICS, 2002, 24 (03) : 330 - 350
  • [39] Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice
    Radovanovic, Mirjana
    Galettis, Peter
    Flynn, Alex
    Martin, Jennifer H.
    Schneider, Jennifer J.
    PHARMACEUTICALS, 2024, 17 (01)
  • [40] Therapeutic Drug Monitoring of Ziprasidone in a Clinical Treatment Setting
    Cherma, Maria D.
    Reis, Margareta
    Hagg, Staffan
    Ahlner, Johan
    Bengtsson, Finn
    THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 682 - 688
12345